Niels Skakkebaek

Niels Skakkebaek

professor testicular dysgenesis and hormone disruption
在 rh.dk 的电子邮件经过验证
被引用次数：102789
testis cancer male reproduction testicular dysgenesis germ cell neoplasia in situ endocrine disruption
Eric A. Klein

Eric A. Klein

Chairman, Glickman Urological and Kidney Institute, Cleveland Clinic
在 ccf.org 的电子邮件经过验证
被引用次数：70799
Urologic oncology prostate cancer testis cancer kidney cancer bladder cancer
Padraig Warde

Padraig Warde

University of Toronto
在 bell.net 的电子邮件经过验证
被引用次数：28055
Testis Cancer
Andrew Stephenson

Andrew Stephenson

Associate Professor of Surgery, Cleveland Clinic
在 ccf.org 的电子邮件经过验证
被引用次数：18359
prostate cancer bladder cancer testis cancer kidney cancer predictive models
Marcus Hentrich

Marcus Hentrich

Red Cross Hospital, University of Munich
在 swmbrk.de 的电子邮件经过验证
被引用次数：6183
HIV-malignancies myeloma and lymphoma testis cancer
Scott M Gilbert

Scott M Gilbert

H. Lee Moffitt Cancer Center & Research Institute
在 umich.edu 的电子邮件经过验证
被引用次数：4951
Urologic Oncology Bladder Cancer Testis Cancer Health Services Research Outcomes Research
Costantine Albany

Costantine Albany

Indiana University
在 iu.edu 的电子邮件经过验证
被引用次数：3398
Testis Cancer Epigenetics
Carlo Andrea Bravi

Carlo Andrea Bravi

The Royal Marsden NHS Foundation Trust, London (UK)
在 rmh.nhs.uk 的电子邮件经过验证
被引用次数：2126
Oncology Prostate cancer Testis cancer Kidney cancer Robotic surgery
Prash Patel

Prash Patel

University College London Hospitals (UCLH)
在 nhs.net 的电子邮件经过验证
被引用次数：2085
Urology Bladder Cancer Prostate Cancer Testis Cancer Informatics
Michael Leveridge MD FRCSC

Michael Leveridge MD FRCSC

Associate Professor, Departments of Urology and Oncology, Queen's University
在 kingstonhsc.ca 的电子邮件经过验证
被引用次数：2062
urology kidney cancer prostate cancer bladder cancer testis cancer
1 - 10